Lv51
1220 积分 2022-09-18 加入
Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy
2小时前
已完结
Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment
4个月前
已完结
Radiation-induced coronary artery disease during immune checkpoint inhibitor therapy: a case report
4个月前
已完结
Cardiovascular Risk in Cancer Patients Treated with Immune Checkpoint Inhibitors: Challenges and Future Directions
4个月前
已完结
Cancer Chemotherapy-Induced Sinus Bradycardia: A Narrative Review of a Forgotten Adverse Effect of Cardiotoxicity
6个月前
已完结
The mechanism and treatment of targeted anti-tumour drugs induced cardiotoxicity
6个月前
已完结
Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches
10个月前
已完结
Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial
10个月前
已完结
Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy
10个月前
已完结
Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation
10个月前
已完结
皖公网安备34019202002308
